Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2019-06-15
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical EXercise as an Adjunct Treatment for Depression
NCT02612142
Prevention of Depressive Relapse by Means of Physical Exercise and Lifestyle
NCT02599597
Treating Depression With Physical Exercise
NCT01573130
Initiating and Maintaining Physical Activity in Depressed Individuals
NCT02691845
Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression
NCT02176408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
This arm will consist of healthy overweight and obese individuals who are physically inactive and do not have clinically diagnosed depression or depression symptoms.
Exercise
The intervention consists of 180 minutes of moderate-vigorous aerobic exercise per week for 6 weeks.
Antidpressants
This arm will consist of healthy overweight and obese adults who are physically inactive and who are diagnosed with clinical depression and have been taking antidepressant medications for at least 1 year.
Exercise
The intervention consists of 180 minutes of moderate-vigorous aerobic exercise per week for 6 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
The intervention consists of 180 minutes of moderate-vigorous aerobic exercise per week for 6 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or females between the ages of 18-40.
* All genders and ethnicities.
* Healthy as assessed by a health history questionnaire (no diagnosed physical diseases or conditions preventing participation in exercise).
* Individuals on antidepressants will be recruited if they are consuming selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs) only. Participants will send prescription information after consent has been provided as part of the screening process, including the dose and frequency of medication.
* A body mass index (BMI) of 25 or greater is required for inclusion.
Exclusion Criteria
* Taking first generation antidepressant medications or other medications such as monoamine oxidase inhibitors (MAOI).
* Other medications, such as medications for attention-deficit hyper-activity disorder or metabolism
* Undiagnosed depression that may be unveiled during the screening process.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
California State University, San Marcos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew Schubert
Assistant Professor of Kinesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
California State University San Marcos
San Marcos, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1423972-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.